Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
about
Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcomaEpithelioid Sarcoma: Opportunities for Biology-Driven Targeted TherapyDifferences in irradiated lung gene transcription between fibrosis-prone C57BL/6NHsd and fibrosis-resistant C3H/HeNHsd mice.In Silico Analysis and Experimental Validation of Active Compounds from Cichorium intybus L. Ameliorating Liver Injury.IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survivalWhole Exome- and mRNA-Sequencing of an AT/RT Case Reveals Few Somatic Mutations and Several Deregulated Signalling Pathways in the Context of SMARCB1 Deficiency.Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma.ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.Molecular biology of pediatric brain tumors and impact on novel therapies.Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress.Epigenomic regulation of oncogenesis by chromatin remodeling.Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells.SNF5 as a prognostic factor in skull base chordoma.
P2860
Q21245750-CCDD6B1D-CF1A-4096-8255-69CEA6DEA640Q26782730-1CF046A6-FAEB-4B59-83D1-FE87CBE9F7B8Q33820556-8A2685DB-8936-425E-BF4D-5734E01F7D9DQ35781833-942BB422-0646-4FF9-9090-E3DE9788EE84Q36179660-AAA7A814-2BAC-4B62-B325-143B0A51672BQ36657085-19C3BEC7-5BEA-436F-A578-701EA7CFF7C9Q37031704-C1CE7532-B085-4ECF-8BAA-21065929BCB9Q37225222-16A3096A-2EEC-4437-A254-2305632175C4Q38359284-B86C7CA5-4996-4AB6-9609-80B9DD307478Q38682244-2DFDD659-2568-4878-8563-1A5A44C513F3Q38709544-A9881EF8-5663-42DA-B725-F1A75010567DQ38835302-FEAB2608-E81E-4651-AFD1-D239A3F79DC5Q47925228-F4798305-A58D-4C6C-BE5F-BFFD611727C3
P2860
Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.
@en
Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.
@nl
type
label
Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.
@en
Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.
@nl
prefLabel
Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.
@en
Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.
@nl
P2093
P2860
P356
P1433
P1476
Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2013.261
P407
P577
2013-07-15T00:00:00Z